These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 20201847)

  • 1. Agonist-like pharmacotherapy for stimulant dependence: preclinical, human laboratory, and clinical studies.
    Herin DV; Rush CR; Grabowski J
    Ann N Y Acad Sci; 2010 Feb; 1187():76-100. PubMed ID: 20201847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence.
    Grabowski J; Shearer J; Merrill J; Negus SS
    Addict Behav; 2004 Sep; 29(7):1439-64. PubMed ID: 15345275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychostimulant treatment of cocaine dependence.
    Mariani JJ; Levin FR
    Psychiatr Clin North Am; 2012 Jun; 35(2):425-39. PubMed ID: 22640764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The principles of agonist pharmacotherapy for psychostimulant dependence.
    Shearer J
    Drug Alcohol Rev; 2008 May; 27(3):301-8. PubMed ID: 18368612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential for misuse and abuse of medications in ADHD: a review.
    Clemow DB; Walker DJ
    Postgrad Med; 2014 Sep; 126(5):64-81. PubMed ID: 25295651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abuse liability assessment in preclinical drug development: predictivity of a translational approach for abuse liability testing using methylphenidate in four standardized preclinical study models.
    Teuns GB; Geys HM; Geuens SM; Stinissen P; Meert TF
    J Pharmacol Toxicol Methods; 2014; 70(3):295-309. PubMed ID: 24632211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapy of amphetamine-type stimulant dependence: an update.
    Brensilver M; Heinzerling KG; Shoptaw S
    Drug Alcohol Rev; 2013 Sep; 32(5):449-60. PubMed ID: 23617468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulants for depression: On the up and up?
    Malhi GS; Byrow Y; Bassett D; Boyce P; Hopwood M; Lyndon W; Mulder R; Porter R; Singh A; Murray G
    Aust N Z J Psychiatry; 2016 Mar; 50(3):203-7. PubMed ID: 26906078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological Treatment of Methamphetamine/Amphetamine Dependence: A Systematic Review.
    Siefried KJ; Acheson LS; Lintzeris N; Ezard N
    CNS Drugs; 2020 Apr; 34(4):337-365. PubMed ID: 32185696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoamine transporter inhibitors and substrates as treatments for stimulant abuse.
    Howell LL; Negus SS
    Adv Pharmacol; 2014; 69():129-76. PubMed ID: 24484977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing the abuse potential of methylphenidate versus other stimulants: a review of available evidence and relevance to the ADHD patient.
    Kollins SH
    J Clin Psychiatry; 2003; 64 Suppl 11():14-8. PubMed ID: 14529325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of ADHD and its treatment on substance abuse in adults.
    Wilens TE
    J Clin Psychiatry; 2004; 65 Suppl 3():38-45. PubMed ID: 15046534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abuse and dependence liability analysis of methylphenidate in the spontaneously hypertensive rat model of attention-deficit/hyperactivity disorder (ADHD): what have we learned?
    Dela Peña I; Kim BN; Han DH; Kim Y; Cheong JH
    Arch Pharm Res; 2013 Apr; 36(4):400-10. PubMed ID: 23471559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aripiprazole as a potential pharmacotherapy for stimulant dependence: human laboratory studies with d-amphetamine.
    Stoops WW
    Exp Clin Psychopharmacol; 2006 Nov; 14(4):413-21. PubMed ID: 17115868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacotherapy of addictive disorders.
    Ross S; Peselow E
    Clin Neuropharmacol; 2009; 32(5):277-89. PubMed ID: 19834993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacotherapy of methamphetamine addiction: an update.
    Elkashef A; Vocci F; Hanson G; White J; Wickes W; Tiihonen J
    Subst Abus; 2008; 29(3):31-49. PubMed ID: 19042205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Substitution therapy tested against amphetamine dependence].
    Bloniecki Kallio V; Guterstam J; Franck J
    Lakartidningen; 2016 Jan; 113():. PubMed ID: 26756343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of stimulant treatment in attention deficit hyperactivity disorder: Part I.
    Merkel RL; Kuchibhatla A
    Expert Opin Drug Saf; 2009 Nov; 8(6):655-68. PubMed ID: 19785509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and characteristics of adolescents patients with co-occurring ADHD and substance dependence.
    Gordon SM; Tulak F; Troncale J
    J Addict Dis; 2004; 23(4):31-40. PubMed ID: 15339712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of treating cathinone dependence and comorbid depression using bupropion.
    Lev-Ran S
    J Psychoactive Drugs; 2012; 44(5):434-6. PubMed ID: 23457895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.